Entinostat-induced PD-L1 expression was observed in bladder and ovarian cancers [13,36], which was consistent with our data showing that entinostat significantly upregulated the PD-1/PD-L1 pathway genes. Here, PDCD1 is linked to ovarian carcinoma.